骨髓和其他造血系统恶性肿瘤的种系CHEK2和ATM变体

IF 2.7 3区医学 Q2 HEMATOLOGY

Current Hematologic Malignancy Reports Pub Date : 2022-06-08 DOI:10.1007/s11899-022-00663-7

Ryan J. Stubbins, S. Korotev, L. Godley

引用次数: 15

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies

查看原文本刊更多论文

Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Current Hematologic Malignancy Reports ONCOLOGY-HEMATOLOGY

CiteScore

6.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： his journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hematologic malignancy. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as leukemia, lymphoma, myeloma, and T-cell and other lymphoproliferative malignancies. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.